Risk Factors for Thyroid Dysfunction in Pregnancy: An Individual Participant Data Meta-Analysis
- 24 May 2024
- journal article
- research article
- Published by SAGE Publications in Thyroid®
- Vol. 34 (5) , 646-658
Abstract
Background: International guidelines recommend targeted screening to identify gestational thyroid dysfunction. However, currently used risk factors have questionable discriminative ability. We quantified the risk for thyroid function test abnormalities for a subset of risk factors currently used in international guidelines. Methods: We included prospective cohort studies with data on gestational maternal thyroid function and potential risk factors (maternal age, body mass index [BMI], parity, smoking status, pregnancy through in vitro fertilization, twin pregnancy, gestational age, maternal education, and thyroid peroxidase antibody [TPOAb] or thyroglobulin antibody [TgAb] positivity). Exclusion criteria were pre-existing thyroid disease and use of thyroid interfering medication. We analyzed individual participant data using mixed-effects regression models. Primary outcomes were overt and subclinical hypothyroidism and a treatment indication (defined as overt hypothyroidism, subclinical hypothyroidism with thyrotropin >10 mU/L, or subclinical hypothyroidism with TPOAb positivity). Results: The study population comprised 65,559 participants in 25 cohorts. The screening rate in cohorts using risk factors currently recommended (age >30 years, parity ≥2, BMI ≥40) was 58%, with a detection rate for overt and subclinical hypothyroidism of 59%. The absolute risk for overt or subclinical hypothyroidism varied p < 0.001), subclinical hypothyroidism (risk for antibody negativity 2.2%, isolated TgAb positivity 8.1%, isolated TPOAb positivity 14.2%, combined antibody positivity 20.0%; p < 0.001) and a treatment indication (risk for antibody negativity 0.2%, isolated TgAb positivity 2.2%, isolated TPOAb positivity 3.0%, and combined antibody positivity 5.1%; p < 0.001). Twin pregnancy was associated with a higher risk of overt hyperthyroidism (5.6% vs. 0.7%; p < 0.001). Conclusions: The risk factors assessed in this study had poor predictive ability for detecting thyroid function test abnormalities, questioning their clinical usability for targeted screening. As expected, TPOAb positivity (used as a benchmark) was a relevant risk factor for (subclinical) hypothyroidism. These results provide insights into different risk factors for gestational thyroid dysfunction.Keywords
This publication has 55 references indexed in Scilit:
- The targeted high-risk case-finding approach versus universal screening for thyroid dysfunction during pregnancy: thyroid-stimulating hormone (TSH) and/or thyroid peroxidase antibody (TPOAb) test?Journal of Endocrinological Investigation, 2022
- Association between maternal thyroid function and risk of gestational hypertension and pre-eclampsia: a systematic review and individual-participant data meta-analysisThe Lancet Diabetes & Endocrinology, 2022
- Association of maternal thyroid function with birthweight: a systematic review and individual-participant data meta-analysisThe Lancet Diabetes & Endocrinology, 2020
- Association of Thyroid Function Test Abnormalities and Thyroid Autoimmunity With Preterm BirthJAMA, 2019
- Reference ranges and determinants of total hCG levels during pregnancy: the Generation R StudyEuropean Journal of Epidemiology, 2015
- Effect of thyroid dysfunction and autoimmunity on pregnancy outcomes in low risk populationArchives of Gynecology and Obstetrics, 2014
- Tobacco and pregnancy: Overview of exposures and effectsBirth Defects Research Part C: Embryo Today: Reviews, 2008
- The Colorado Thyroid Disease Prevalence StudyArchives of internal medicine (1960), 2000
- The thyrotrophic role of human chorionic gonadotrophin (hCG) in the early stages of twin (versus single) pregnanciesClinical Endocrinology, 1997
- Decreased maternal serum hcg levels with increasing gravidity and parityObstetrics & Gynecology, 1995